VR Adviser as of June 30, 2024
Portfolio Holdings for VR Adviser
VR Adviser holds 35 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apogee Therapeutics (APGE) | 21.3 | $334M | 8.5M | 39.35 | |
| Enliven Therapeutics (ELVN) | 6.0 | $94M | 4.0M | 23.37 | |
| 4d Molecular Therapeutics In (FDMT) | 5.9 | $92M | 4.4M | 20.99 | |
| Ocular Therapeutix (OCUL) | 5.6 | $87M | 13M | 6.84 | |
| Dyne Therapeutics (DYN) | 4.9 | $77M | 2.2M | 35.29 | |
| Merus N V (MRUS) | 4.8 | $75M | 1.3M | 59.17 | |
| Kalvista Pharmaceuticals (KALV) | 4.7 | $74M | 6.2M | 11.78 | |
| Pharvaris N V (PHVS) | 4.1 | $64M | 3.4M | 18.80 | |
| Spyre Therapeutics Com New (SYRE) | 4.0 | $63M | 2.7M | 23.51 | |
| Dianthus Therapeutics (DNTH) | 3.5 | $54M | 2.1M | 25.88 | |
| Miragen Therapeutics (VRDN) | 3.2 | $51M | 3.9M | 13.01 | |
| Cogent Biosciences (COGT) | 3.1 | $48M | 5.7M | 8.43 | |
| Applied Therapeutics (APLT) | 2.8 | $45M | 9.5M | 4.67 | |
| Erasca (ERAS) | 2.4 | $38M | 16M | 2.36 | |
| Astria Therapeutics (ATXS) | 2.1 | $33M | 3.6M | 9.10 | |
| Edgewise Therapeutics (EWTX) | 2.1 | $33M | 1.8M | 18.01 | |
| Oric Pharmaceuticals (ORIC) | 2.0 | $31M | 4.4M | 7.07 | |
| Praxis Precision Medicines I Com New (PRAX) | 1.9 | $29M | 706k | 41.36 | |
| Engene Holdings (ENGN) | 1.7 | $27M | 2.8M | 9.43 | |
| Cullinan Oncology (CGEM) | 1.5 | $24M | 1.4M | 17.44 | |
| Terns Pharmaceuticals (TERN) | 1.5 | $23M | 3.4M | 6.81 | |
| Mersana Therapeutics | 1.5 | $23M | 11M | 2.01 | |
| Zura Bio Class A Ord Shs (ZURA) | 1.3 | $21M | 6.0M | 3.50 | |
| Taysha Gene Therapies Com Shs (TSHA) | 1.3 | $20M | 9.0M | 2.24 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.1 | $18M | 1.3M | 13.22 | |
| Arvinas Ord (ARVN) | 1.1 | $17M | 628k | 26.62 | |
| Aquestive Therapeutics (AQST) | 0.9 | $14M | 5.6M | 2.60 | |
| Century Therapeutics (IPSC) | 0.9 | $14M | 5.4M | 2.55 | |
| Cabaletta Bio (CABA) | 0.7 | $12M | 1.6M | 7.48 | |
| Trevi Therapeutics (TRVI) | 0.6 | $10M | 3.4M | 2.98 | |
| Adverum Biotechnologies Com New (ADVM) | 0.6 | $10M | 1.5M | 6.86 | |
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.5 | $7.5M | 750k | 10.06 | |
| Tenaya Therapeutics (TNYA) | 0.3 | $4.8M | 1.6M | 3.10 | |
| Arca Biopharma (ABIO) | 0.2 | $3.3M | 866k | 3.83 | |
| Casi Pharmaceuticals Ord Shs (CASI) | 0.0 | $614k | 112k | 5.50 |
